Expression of transforming growth factor (TGF)-β1 and TGF-β type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats

Toxicologic Pathology

Volumn 29, Issue 5, 2001, Pages 541-549

  Do Youn Park, ^a   Soon Yeol Hwang, ^a   Kang Suek Suh, ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Apoptosis; Chemical hepatocarcinogenesis; Immunohistochemistry; Northern blot; Preneoplastic lesions; Rat; TGF type II receptor; TGF 1

Indexed keywords

DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; CARCINOGENS; CELL COUNT; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATECTOMY; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA;

EID: 0034759261     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301317226348     Document Type: Article

References (37)

1. Transforming growth factor-betas and their signaling receptors in human hepatocellular carcinoma
2. Cell-specific expression of transforming growth factor-β in rat liver
3. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters
4. TGF-β1 inhibits the formation of benign skin tumors but enhance progression to invasive spindle carcinomas in transgenic mice
5. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible wistar rat strain
6. Transforming growth factor β1; comparative immunohistochemical localization in human primary and metastatic prostate cancer
7. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat
8. Hepatocarcinogenesis: A dynamic cellular perspective
9. Induction of apoptosis by TGF-beta 1 in the rat hepatoma cell line MCA-RH7777; a possible association with tissue transglutaminase expression
10. Resistance to inhibition of cell growth by transforming growth factor β and its role in oncogenesis
11. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor beta
12. Growth inhibition by transforming growth factor type I is restored in TGF-beta resistant hepatoma cells after expression of TGF-beta receptor type II cDNA
13. Terminology of nodular hepatocellular lesions
14. Elevated levels of transforming growth factor-beta messenger RNA and its polypeptide in human hepatocellular carcinoma
15. Transforming growth factor-beta; an important mediator of immunoregulation
16. Regulation of selection of liver nodules initiated with N-nitrosodiethylamine and promoted with nodularin injections in Fischer 344 male rats by reciprocal expression of transforming growth factor-β1 and its receptors
17. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor-beta 1
18. Cellular receptors for type beta transforming growth factor: Ligand binding and affinity labeling in human and rodent cell lines
19. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor-alpha in hepatic oncogenesis
20. Expression of transforming growth factor-β1 during chemical hepatocarcinogenesis in the rat
21. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells
22. C-myc amplification in premalignant and malignant lesions induced in rat liver by the resistant hepatocyte model
23. Mammary tumor suppression by transforming growth factor β1 transgenic expression
24. Effect of transforming growth factor beta on rat hepatocyte cell lines depends upon the state of tumorigenic progression
25. Transforming growth factor-β1 receptors type I, II and III in phenobarbital-promoted rat liver tumors
26. Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor-alpha in transgenic mice in associated with TGF-β1 signaling disruption
27. Apoptosis in the liver and its role in hepatocarcinogenesis
28. TGF-β1 receptors: A complicated system of multiple binding proteins
29. Plasma transforming growth factor-betal in patients with hepatocellular carcinoma
30. Rapid emergence of carcinogeninduced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis
31. Different inhibition of DNA synthesis by transforming growth factor β and phenobarbital on GST-P-positive and GST-P-negative hepatocytes
32. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver
33. Expression of PDGF, IGF-II, bFGF and TGF-β1 in pulmonary adenocarcinoma
34. Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of gamma-glutamyltransferase in rat liver preneoplastic and neoplastic lesions
35. Molecular characterization of rat transforming growth factor-β type II receptor
36. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta
37. Mechanism of activation of the TGF-β receptor